BioAge Labs, Inc. SEC filings BIOA
BioAge Labs, Inc. has 157 filings in SEC EDGAR's recent list, going back to Feb 13, 2024. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Sep 25, 2024 | — |
| EFFECT | Filing | Sep 25, 2024 | — |
| CERT | Filing | Sep 25, 2024 | — |
| CORRESP | Letter to the SEC | Sep 25, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2024 | — |
| CORRESP | Letter to the SEC | Sep 23, 2024 | — |
| CORRESP | Letter to the SEC | Sep 23, 2024 | — |
| CORRESP | Letter to the SEC | Sep 18, 2024 | — |
| 8-A12B | Filing | Sep 18, 2024 | — |
| CORRESP | Letter to the SEC | Sep 12, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2024 | — |
| DRSLTR | Filing | Aug 5, 2024 | — |
| DRS/A | Filing | Aug 5, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| DRSLTR | Filing | Jul 3, 2024 | — |
| DRS/A | Filing | Jul 3, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 28, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2024 | — |
| DRS | Filing | May 31, 2024 | — |
| D | Filing | Feb 13, 2024 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIOA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1709941
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.